Business Context and Reporting Period
Company: SeaStar Medical Holding Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2024
Reporting Period: This filing reports a specific event occurring on March 27, 2024, regarding an upcoming investor conference call and a financial restatement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of an event rather than a financial statement.
Material Changes
The primary material change disclosed is the Company's intention to restate its financial statements for the following periods:
- Fiscal year ended December 31, 2022
- Interim period ended March 31, 2023
- Interim period ended June 30, 2023
- Interim period ended September 30, 2023
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company announced an investor conference call scheduled for Wednesday, April 17, 2024, at 4:00 p.m. Eastern time (1:00 p.m. Pacific time).
Purpose: The call will provide an operational update and address the intention to restate the financial statements listed above.
Risks and Contingencies: The necessity of restating financial statements for multiple periods indicates potential accounting irregularities or errors, which constitutes a significant risk to historical financial reliability.
Investor Verification Checklist
- Verify the specific accounting errors or adjustments driving the restatement of the 2022 and 2023 periods.
- Review the full text of the press release (Exhibit 99.1) for details on the nature of the restatement.
- Monitor the April 17, 2024, investor conference call for management's explanation of the operational impact.
- Assess whether the restatement affects the Company's compliance with Nasdaq listing standards.